Breadcrumb Location
DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment
Product Details
Other Notes
Ontario health technology assessment series, 1915-7398 ; v. 21, no. 14

